Janssen to Present Data from Six Compounds Including Daratumumab and Ibrutinib at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting .

Darzalex ( Daratumumab )
Imbruvica ( Ibrutinib )
Apalutamide
Yondelis ( Trabectedin )
Zytiga ( Abiraterone )
Xarelto ( Rivaroxaban )


ASCO 2016 Curtain Raiser Press Release DRAFT .

CONFIDENTIAL – Subject to Ongoing Legal, Medical and Regulatory Review .

Media Inquiries: Kellie McLaughlin Phone: 1-908-927-7477 Mobile: 1-609-468-8356 .

Satu Kaarina Glawe Mobile: +49 172 294 6264 .

Investor Relations: Lesley Fishman Phone: 1-732-524-3922 .

U.S. Medical Inquiries: (DARZALEX, ZYTIGA, YONDELIS, XARELTO and apalutamide): 1-800-526-7736 .

(IMBRUVICA – Pharmacyclics/AbbVie): 1-877-877-3536 .

...